LKFTLakefront Biotherapeutics NV
$29.74-13% 1Y
$29.74
$26.0752 weeks$37.62
Is the price fair?
What LKFT's price assumes
Lakefront Biotherapeutics NV did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1.89× revenue.
1.89
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.61
Price / book · as of 2026-Q1
- EV / sales
- 1.83
EV / sales
Details›
- Price / bookas of 2026-Q1
- 0.61
- EV / EBIToperating margin −52%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 1.83
- Market capitalisation
- $1.90B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.